Psychedelic guide credentials are not standardized across the field, which means the quality of support you receive depends heavily on who you choose and how carefully you evaluate them. This post outlines what training actually requires, what licensure does and does...
A psychedelic therapy screening assessment is the structured clinical process that determines whether you are a suitable candidate for psilocybin or similar modalities. For high-performing individuals, it covers psychiatric history, cardiovascular health, current...
This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded in current clinical research, verified legal data, and practical...
Psychedelic tourism is growing fast, and so is the number of people booking retreats abroad with little more than a website and a payment link between them and a high-dose experience. Psychedelic retreat abroad safety depends heavily on who is running the program,...
Research from Johns Hopkins, NYU, and Imperial College London shows that psilocybin long term effects on depression and anxiety can persist well beyond the session itself, with some studies tracking sustained improvements at 6, 12, and even 4.5 years post-treatment....
The JOM11 psychedelic executive program is JourneyOM’s structured, concierge-level pathway for senior leaders who want to address burnout, cognitive rigidity, or performance plateaus through professionally supported psychedelic therapy. Built around eleven...
